Compare MGTX & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | WLFC |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2018 | 1997 |
| Metric | MGTX | WLFC |
|---|---|---|
| Price | $13.84 | $53.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $24.57 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 588.5K | 223.3K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | ★ 33.02 | N/A |
| EPS | 1.30 | ★ 2.39 |
| Revenue | $81,391,000.00 | ★ $569,223,000.00 |
| Revenue This Year | $141.38 | $2.75 |
| Revenue Next Year | N/A | $7.35 |
| P/E Ratio | ★ $10.88 | $23.06 |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $53.40 |
| 52 Week High | $15.35 | $244.62 |
| Indicator | MGTX | WLFC |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 21.48 |
| Support Level | $7.04 | $53.40 |
| Resistance Level | $15.35 | $74.22 |
| Average True Range (ATR) | 0.76 | 2.52 |
| MACD | 0.01 | 4.58 |
| Stochastic Oscillator | 53.08 | 13.72 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.